Oral Oncology
Volume 40, Issue 7 , Pages 705-712 , August 2004

Molecular cloning, isolation and characterisation of ERK3 gene from chewing-tobacco induced oral squamous cell carcinoma

  • Rekha Rai

      Affiliations

    • Laboratory of Cancer Genes, Cancer Research Institute, Tata Memorial Centre, Parel, Mumbai 400012, India
    • Both authors contributed equally to this study.
    • ,
  • Alka Mahale

      Affiliations

    • Laboratory of Cancer Genes, Cancer Research Institute, Tata Memorial Centre, Parel, Mumbai 400012, India
    • Both authors contributed equally to this study.
    • ,
  • Dhananjaya Saranath

      Affiliations

    • Department of Molecular Medicine and Biology, Jaslok Hospital and Research Centre, 15, Dr. G. Deshmukh Marg, Mumbai 400026, India
    • Corresponding Author InformationCorresponding author. Tel.: +91-22-5657-3445; fax: +91-22-2352-0508

Received 10 November 2003 ,Accepted 7 January 2004.

References 

  1. Parkin DM, Whelan SL, Ferlay J, Raymond L, Young J, editors. Cancer incidence in five continents, International Agency for Research on Cancer, Lyon, France: IARC Scientific Publications, 1997;VI(143)
  2. Notani PN. Epidemiology and prevention of head and neck cancer: a global view. In:  Saranath D editors. Contemporary issues in oral cancer. New Delhi: Oxford University Press; 2000;p. 1–29
  3. Saranath D, Panchal RG, Nair R, Mehta AR, Sanghavi V, Sumegi J, et al.  Oncogene amplification in squamous cell carcinoma of the oral cavity. Jpn J Cancer Res. 1989;80:430–437
  4. Saranath D, Panchal RG, Nair R, Mehta AR, Sanghavi V, Deo MG. Amplification and overexpression of epidermal growth factor receptor gene in human oropharyngeal cancer. Oral Oncol Eur J Cancer. 1992;29B:139–143
  5. Saranath D, Chang SE, Bhoite LT, Panchal RG, Kerr IB, Mehta AR, et al.  High frequency mutation in codons 12 and 61 of H-ras oncogene in chewing-tobacco related human oral carcinoma in India. Br J Cancer. 1991;63:573–578
  6. Saranath D, Tandle AT, Teni TR, Dedhia PM, Borges AM, Parikh D, et al.  p53 inactivation in chewing tobacco-induced oral cancers and leukoplakias from India. Oral Oncol. 1999;35:242–250
  7. Kulkarni V, Saranath D. Concurrent hypermethylation of multiple regulatory genes in chewing-tobacco associated oral squamous cell carcinomas and adjacent normal tissues. Oral Oncol. 2003;40:145–153
  8. Mahale A, Saranath D. Microsatellite alterations on chromosome 9 in chewing tobacco induced oral squamous cell carcinomas from India. Oral Oncol. 2000;36:199–206
  9. Tandle AT, Saranath D. Genetic alterations on chromosome 3, p53 tumor suppressor gene and telomerase activity in oral cancers from India. Asia Pac J Cancer Prev. 2000;1(APCC Supplement):219–225
  10. Patriotis C, Makris A, Chernoff J, Tsichlis PN. Tpl-2 acts in concert with Ras and Raf-1 to activate mitogen-activated protein kinase. Proc Natl Acad Sci, USA. 1994;91:9755–9759
  11. Smalley KSM. A pivotal role for ERK in the oncogenic behaviour of malignant melanoma. Int J Cancer. 2003;104:527–532
  12. Sivaraman V, Wang H, Nuovo G, Melbon C. Hyperexpression of mitogen-activated protein in human breast cancer. J Clin Invest. 1997;99:1478–1483
  13. Oka H, Chatani Y, Hoshino R, Ogawa O, Kakehi Y, Terachi T, et al.  Constitutive activation of mitogen-activated (MAP) kinases in human renal cell carcinoma. Cancer Res. 1995;55:4182–4187
  14. Ostrowski J, Trzeciak L, Kolodziejski J, Bomsztyk K. Increased constitutive activity of mitogen-activated protein kinase and renaturable 85 kDa kinase in human colorectal cancer. Br J Cancer. 1998;78:1301–1306
  15. Kiyokawa E, Takai S, Tanaka M, Iwase T, Suzuki M, Ziang YY, et al.  Overexpression of ERK, an EPH family receptor protein tyrosine kinase, in various human tumors. Cancer Res. 1994;54:3645–3650
  16. Mishima K, Yamada E, Masui K, Shimokawara T, Takayama K, Sugimura M, et al.  Overexpression of ERK/MAP kinases in oral squamous cell carcinoma. Mod Pathol. 1998;11:886–891
  17. Zhu AX, Zhao YI, Moller DE, Flier JS. Cloning and characterization of p97MAPK, a novel human homologue of rat ERK-3. Mol Cell Biol. 1994;14:8202–8211
  18. Schaeffer HJ, Weber MJ. Mitogen activated protein kinases: specific messages from ubiquitous messengers. Mol Cell Biol. 1999;19:2435–2444
  19. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate–phenol–chloronol extraction. Anal Biochem. 1987;162:156–159
  20. Saranath D, Bhoite LT, Deo MG, Tandle AT, D' Costa JD, Kolhapure RN, et al.  Detection and cloning of potent transforming gene(s) from chewing tobacco related human oral carcinoma. Oral Oncol Eur J Cancer. 1994;30B:268–277
  21. Garrington TP, Johnson GL. Organization and regulation of mitogen activated protein kinase signalling pathways. Curr Opin Cell Biol. 1999;11:211–218
  22. Chang L, Karin M. Mammalian MAP kinase signalling cascades. Nature. 2001;410:37–40
  23. Boulton TG, Nye SH, Robbins DJ, Ip NY, Radziejewska E, Morgenbesser SD, et al.  ERKS: A family of protein–serine/threonine kinases that are activated and tyrosine phosphorylated in response to insulin and NGF. Cell. 1991;65:663–675
  24. Meloche S. Cell cycle re-entry of mammalian fibroblasts is accompanied by the sustained activation of p44mapk and p42mapk isoforms in G1 phase and their inactivation at G1/S transition. J Cell Physiol. 1995;163:577–588
  25. Lavoie JN, L'Allemain G, Brunet A, Muller R, Pouyssegur J. Cyclin D1 expression is regulated positively by the p42/44MAPK and negatively by the p38/HOGMAPK pathway. J Biol Chem. 1996;271:20608–20616
  26. Sauma S, Freidman E. Increased expression of PKC β activates ERK3. J Biol Chem. 1996;271:11422–11426
  27. Wang Q, Ding Q, Dong Z, Ehlers RA, Evers BM. Downregulation of mitogen activated protein kinase in human colon cancers. Anticancer Res. 2000;20:75–83
  28. Zimmermann J, Lamerant N, Grossenbacher R, Furst P. Proteasome- and p38-dependent regulation of ERK3 expression. J Biol Chem. 2001;276:10759–10766
  29. Coulombe P, Rogier G, Pelletier S, Pellerin J, Meloche S. Rapid turnover of extracellular signal-regulated kinase 3 by the ubiquitin–proteasome pathway defines a novel paradigm of mitogen-activated protein kinase regulation during cellular differentiation. Mol Cell Biol. 2003;23:4542–4558

PII: S1368-8375(04)00023-5

doi: 10.1016/j.oraloncology.2004.01.010

Oral Oncology
Volume 40, Issue 7 , Pages 705-712 , August 2004

Article Tools

* Image Usage & Resolution